25 / 27
1. ©National Comprehensive Cancer Network 2019, All Rights Reserved; 2. Galle PR et al. J Hepatol, 69 (1), July 2018, pp
182-236; 3. Vogel A. et al. Annals of Oncology 29 (Supp 4): iv238–iv255, 2018; 4.
https://www.nice.org.uk/guidance/ta551.Lenvatinib as a 1L treatment option for HCC
Lenvatinib is recommended in
first-line therapy
for aHCC by the most prestigious Clinical
Practice Guidelines for the Management of HCC
1,2,3,4
:
ü
NCCN Guidelines v 1.2019
ü
EASL Guidelines 2018
ü
ESMO Guidelines 2018
ü
NICE Committee
aHCC: advanced or unresectable HCC.